Standard BioTools Inc.
Symbool: LAB
NASDAQ
2.41
USDMarktprijs vandaag
-2.5738
Koers/Winst Verhouding
-0.0737
Koers/Winst Groei Verhouding
923.15M
MRK Kapitalisatie
- 0.00%
DIV Rendement
Standard BioTools Inc. (LAB) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 114.9 | 165.8 | 28.5 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 63.2 | 84.5 | 0 | |||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 19.7 | 17.3 | 18.3 | |||||||||||||||||||
balance-sheet.row.inventory | 0 | 20.5 | 21.5 | 20.8 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 3.1 | 4.3 | 4.5 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 158.2 | 208.8 | 72.1 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 54.9 | 59.5 | 65.2 | |||||||||||||||||||
balance-sheet.row.goodwill | 0 | 106.3 | 106.3 | 106.4 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 1.4 | 12.6 | 27.9 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 107.7 | 118.9 | 134.3 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0.8 | 1 | 1 | |||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | -1 | -1 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 1.5 | 3.1 | 3.7 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 164.9 | 181.5 | 203.1 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-assets | 0 | 323.1 | 390.3 | 275.2 | |||||||||||||||||||
balance-sheet.row.account-payables | 0 | 9.2 | 7.9 | 10.6 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 63.9 | 5.8 | 9.9 | |||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 1.2 | 1.2 | 1.4 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 4 | 96.9 | 101.8 | |||||||||||||||||||
Deferred Revenue Non Current | 0 | 14.3 | 18.2 | 24.1 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 20.6 | 15.3 | 13.6 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 50.5 | 428.3 | 131.1 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 30.4 | 37.8 | 40.6 | |||||||||||||||||||
balance-sheet.row.total-liab | 0 | 159.9 | 471.8 | 180.6 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 311.3 | 311.3 | 0 | |||||||||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -1000.8 | -926.1 | -736 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -2.2 | -1.9 | -0.9 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 854.8 | 535.2 | 831.4 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 163.2 | -81.5 | 94.6 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 323.1 | 390.3 | 275.2 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-equity | 0 | 163.2 | -81.5 | 94.6 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||
Total Investments | 0 | 64 | 84.5 | 1 | |||||||||||||||||||
balance-sheet.row.total-debt | 0 | 98.2 | 102.7 | 111.6 | |||||||||||||||||||
balance-sheet.row.net-debt | 0 | 46.5 | 21.3 | 83.2 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -74.7 | -190.1 | -59.2 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 15.2 | 15 | 15.6 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 6.3 | 0 | 0 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 13.1 | 14.9 | 16.1 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 1.8 | -15.5 | -19.9 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | -3 | 1.1 | 6.7 | |||||||||||||||||||
cash-flows.row.inventory | 0 | -4.9 | -8.5 | -4.8 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | 1.6 | -2.8 | 1.3 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 8.1 | -5.3 | -23.2 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -5 | 86.3 | 3.4 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -2.8 | -3.8 | -13.3 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 84.3 | 0 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -94.9 | -137.3 | 0 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 118 | 53 | 0 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -84.3 | 1.3 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 20.2 | -88.1 | -11.9 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -2.1 | -6.8 | -0.5 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0.8 | 225 | 1.5 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -5.4 | -0.6 | -1.8 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -0.3 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -0.1 | 13.2 | 17.1 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -6.8 | 230.8 | 16 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | -0.4 | 0 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -29.6 | 52.9 | -40.1 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 51.7 | 82.3 | 29.5 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 81.3 | 29.5 | 69.5 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -43.3 | -89.4 | -44.1 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -2.8 | -3.8 | -13.3 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -46.1 | -93.2 | -57.3 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 106.3 | 97.9 | 130.6 | |||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 55.9 | 60.9 | 61.2 | |||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 50.5 | 37.1 | 69.4 | |||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 7 | -12.3 | 7.6 | |||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 113.5 | 153.3 | 136.8 | |||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 169.4 | 214.2 | 198 | |||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 4.3 | 0.3 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 4.6 | 4.3 | 3.8 | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -11.2 | -76.7 | 3.8 | |||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 7 | -12.3 | 7.6 | |||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -11.2 | -76.7 | 3.8 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 4.6 | 4.3 | 3.8 | |||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 15.2 | 2.7 | 23.2 | |||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.operating-income | 0 | -63 | -116.2 | -67.5 | |||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -74.2 | -192.9 | -63.7 | |||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 0.5 | -2.8 | -4.4 | |||||||||||||||||||
income-statement-row.row.net-income | 0 | -74.7 | -190.1 | -59.2 |
Vaak gestelde vragen
Wat is Standard BioTools Inc. (LAB) totale activa?
Standard BioTools Inc. (LAB) totale activa is 323067000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.472.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -0.702.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -0.659.
Wat is Standard BioTools Inc. (LAB) nettowinst (netto-inkomen)?
De nettowinst is -74656000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 98210000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 113489000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.